Farahani P. LACK OF HEALTH-RELATED QUALITY OF LIFE AND PATIENT-CENTRED OUTCOME MEASURES IN RANDOMIZED CONTROLLED TRIALS CONDUCTED FOR DIABETES PHARMACOTHERAPY: SGLT-2 RECEPTOR INHIBITORS AS AN EXAMPLE. J Popl Ther Clin Pharmacol. 2018;24(1). Accessed November 19, 2024. https://mail.jptcp.com/index.php/jptcp/article/view/132